CoaguSense, Inc., a leading developer of point-of-care coagulation monitoring systems and a subsidiary of i-SENS, Inc. (KOSDAQ: 099190), today announced ...

The addition of the DOASENSE product suite complements the recent European IVDR approval of the Coag-Sense ® PT/INR Monitoring System for patient self-testing, positioning CoaguSense as a versatile ...

This study aims to establish an interpretable disease classification model via machine learning and identify key features related to the disease to assist clinical disease diagnosis based on a ...

Up to 80% of surgeries for women with suspected ovarian cancer turn out to be unnecessary. Proseek Bio wants to change that.

WASHINGTON, Nov. 4, 2025 /PRNewswire/ -- The Association for Diagnostics & Laboratory Medicine (ADLM, formerly AACC) has issued expert guidance on coagulation testing in patients taking blood thinners ...

Andembry (garadacimab-gxii) is a prescription drug that’s used to help prevent attacks of hereditary angioedema (HAE) in adults and certain children. Andembry comes as a liquid solution that’s given ...

According to published literature, up to 65% of errors occur in the preanalytical phase of laboratory testing, and coagulation assays are particularly sensitive to preanalytical issues. Coagulation ...

Introduction: Severe COVID-19 has been associated with aberrant coagulation factor activities, particularly in patients with a thrombotic event (TE). Management of anticoagulant is critical in the ...

The following is a summary of “A clot waveform analysis-based system for differential diagnosis of prolonged activated partial thromboplastin time in plasma samples,” published in the December 2024 ...